Switch to:
More From Other Websites
PDL BioPharma Agrees to Equity Investment in Noden Pharma May 25 2016
PDL’s Next Acquisition Target Focus Is on Hypertension May 24 2016
PDL BioPharma Commits to Equity Investment in Noden Pharma for the Acquisition of Tekturna®... May 24 2016
PDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... May 24 2016
PDL BioPharma Commits to Equity Investment in Noden Pharma for the Acquisition of Tekturna®... May 24 2016
ETF’s with exposure to PDL BioPharma, Inc. : May 23, 2016 May 23 2016
ETF’s with exposure to PDL BioPharma, Inc. : May 12, 2016 May 12 2016
PDL BIOPHARMA, INC. Financials May 12 2016
PDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... May 11 2016
PDL BioPharma, Inc. :PDLI-US: Earnings Analysis: Q1, 2016 By the Numbers May 10 2016
PDL BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : PDLI-US : May 5, 2016 May 05 2016
Edited Transcript of PDLI earnings conference call or presentation 4-May-16 8:30pm GMT May 04 2016
PDL BioPharma posts 1Q profit May 04 2016
PDL BioPharma posts 1Q profit May 04 2016
PDL BioPharma Announces 2016 Second Quarter Dividend May 04 2016
PDL BioPharma Announces First Quarter 2016 Financial Results May 04 2016
PDL BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... May 04 2016
PDL BioPharma Announces First Quarter 2016 Financial Results May 04 2016
PDL BioPharma Announces 2016 Second Quarter Dividend May 04 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK